Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.6115 | 0.7577 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0018 | 0.0356 | 0.0366 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0064 | 0.7454 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0038 | 0.3498 | 0.4427 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.9288 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.6115 | 0.6115 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.1664 | 0.1664 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0064 | 0.7454 | 1 |
Echinococcus multilocularis | lamin | 0.0029 | 0.2006 | 0.2325 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0776 | 0.0891 |
Schistosoma mansoni | intermediate filament proteins | 0.0029 | 0.2006 | 0.2432 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.1924 | 0.1755 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1363 | 0.1127 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.6115 | 0.8114 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.1363 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.4298 | 0.4413 |
Brugia malayi | intermediate filament protein | 0.0029 | 0.2006 | 0.2006 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.6115 | 0.8114 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0356 | 0.0366 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.1363 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.1363 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.1363 | 0.5 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.127 | 0.1287 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.6115 | 0.8114 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0356 | 0.0366 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.1363 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0041 | 0.3892 | 0.3892 |
Echinococcus granulosus | intermediate filament protein | 0.0029 | 0.2006 | 0.2325 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.6115 | 0.6448 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0019 | 0.0458 | 0.0114 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0038 | 0.3498 | 0.4427 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.127 | 0.1287 |
Brugia malayi | hypothetical protein | 0.0025 | 0.1363 | 0.1363 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.2006 | 0.1847 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0776 | 0.0592 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.6115 | 0.8114 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.1363 | 0.5 |
Echinococcus multilocularis | lamin dm0 | 0.0029 | 0.2006 | 0.2325 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0952 | 0.1112 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.6115 | 0.7577 |
Schistosoma mansoni | lamin | 0.0029 | 0.2006 | 0.2432 |
Echinococcus granulosus | lamin dm0 | 0.0029 | 0.2006 | 0.2325 |
Echinococcus granulosus | lamin | 0.0029 | 0.2006 | 0.2325 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.1363 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.3904 | 0.3972 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0776 | 0.0592 |
Schistosoma mansoni | bromodomain containing protein | 0.0068 | 0.805 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0029 | 0.2006 | 0.1847 |
Onchocerca volvulus | 0.0029 | 0.2006 | 0.5 | |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.127 | 0.151 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0029 | 0.2006 | 0.2006 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0952 | 0.0667 |
Echinococcus multilocularis | musashi | 0.0029 | 0.2006 | 0.2325 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.1363 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.6115 | 0.7577 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0018 | 0.0356 | 0.0366 |
Onchocerca volvulus | 0.0029 | 0.2006 | 0.5 | |
Schistosoma mansoni | lamin | 0.0029 | 0.2006 | 0.2432 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.4616 | 0.4769 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0029 | 0.2006 | 0.1847 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 20.7865 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (binding) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Saccharomyces cerevisiae | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.